The American Cancer Society
estimates that in 2016, about 22,280 new cases of ovarian cancer will be
diagnosed and 14,240 women will die of ovarian cancer in the U.S. Mortality
rates for ovarian cancer have declined only slightly in the forty years since the
“War on Cancer” was declared. However, other cancers have shown a much greater
reduction in mortality, due to the availability of early detection tests and
improved treatments. The Surveillance, Epidemiology and End Results (SEER)
Program reported that in 2012 in the U.S. approximately 192,446 women were
alive who had been diagnosed with ovarian cancer (including those who had been
cured of the disease).
Early detection of cancer is the
key to using the medicines available today to battle cancer and give the
patient the best chance of beating this horrible disease and getting back to a
normal life. Avant Diagnostics, Inc. (OTCQB: AVDX) has undertaken this heroic
challenge with its OvaDx Pre-Symptomatic Ovarian Cancer Screening Test.
OvaDx is a sophisticated
microarray-based test that measures the activation of the immune system in
blood samples in response to early stage ovarian tumor cell development. Upon
commercialization, it’s estimated that the market opportunity for OvaDX could
be $50 million annually as a diagnostic test for ovarian cancer, and it could
expand to over $2 billion if the test were to be approved as a generalized
screening and/or monitoring tool.
Some form of cancer has affected
almost every family in the U.S. either personally or through a member of their
immediate family. The common denominator between cancer and any ailment is that
the earlier it is detected, the better your chances of survival. Continual
monitoring of treatment coupled with early detection can better the odds significantly
and prolong your lifespan. If someone gets tested regularly and detects ovarian
cancer early, their five-year survival rate is 93 percent compared to a
five-year survival rate of only 18 percent if detected in the later stages.
For more information, visit the
company website at www.avantdiagnostics.com
About QualityStocks
QualityStocks is committed to connecting subscribers with
companies that have huge potential to succeed in the short and long-term
future. We offer several ways for investors to find, evaluate, and learn more
about investing in these companies.
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment